Vantage logo

Biopharma takeovers dry up

If the first quarter was quiet for takeovers the second saw M&A grind to a halt. What can the matter be?

Vantage logo

Why not bapineuzumab?

Like Aduhelm this long-discontinued amyloid beta MAb reduced brain beta amyloid; so have several other industry projects.

Vantage logo

Recycling pays off for Mereo

The company has spent five years buying in discontinued projects, and at last has managed to sell one of these on at a nice profit.